Trial intelligence / Profile preview

Adalimumab with or without methotrexate for moderate to severe psoriasis

NL-OMON24479Recruiting

Sponsor
Academic Medical Center
Start
Mar 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of adalimumab and methotrexate in plaque psoriasis (2 arms), sponsored by Academic Medical Center. Primary endpoint: Drug survival at 1 year. Started Mar 2014; status: recruiting.

02

Drugs

adalimumabmethotrexate
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NL-OMON24479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call